2H-色烯-3-甲醛 | 51593-69-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 中文名称: 2H-色烯-3-甲醛
• 中文别名: 2H-色酮-3-甲醛
• 英文名称: 2H-chromene-3-carbaldehyde
• 英文别名: 3-Formyl-2-H-chromen；2H-chromen-3-ylcarbaldehyde
• CAS: 51593-69-2
• 化学式: C₁₀H₈O₂
• mdl: MFCD01662414
• 分子量: 160.172
• InChiKey: RISKINCQRSLFRK-UHFFFAOYSA-N

物化性质

• 熔点：
  170-174 °C
• 沸点：
  106 °C
• 密度：
  1.279±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36
• WGK Germany：
  3
• RTECS号：
  DJ2220000
• 海关编码：
  2912190090
• 安全说明：
  S26
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  保持贮藏器密封，并将其放入一个紧密封装的容器中。储存在阴凉、干燥的地方。

SDS

Name:	2H-chromene-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS:	51593-69-2

Section 1 - Chemical Product MSDS Name:2H-chromene-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
51593-69-2	2H-Chromene-3-carbaldehyde	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 51593-69-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 104 - 106 deg C @0.4mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H8O2
Molecular Weight: 160.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 51593-69-2: DJ2220000 LD50/LC50:
Not available.
Carcinogenicity:
2H-Chromene-3-carbaldehyde - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 51593-69-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 51593-69-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 51593-69-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2H-色烯-3-甲醛 在 aldehyde dehydrogenase from E_.coli 、 β-烟酰胺腺嘌呤二核苷酸 作用下， 以 aq. phosphate buffer 、 二甲基亚砜 为溶剂， 反应 5.0h， 生成 2H-苯并吡喃-3-甲酸
  参考文献：
  名称：

  开发生物催化借氢级联的系统方法：应用于从 α-取代的 α,β-不饱和醛合成手性 α-取代的羧酸†

  摘要：

  烯还原酶 (ER) 是黄素依赖性酶，可催化活性碳-碳双键的不对称还原。特别是 α,β-不饱和羰基化合物（例如enals 和 enones) 以及硝基烯烃被迅速还原。相反，α,β-不饱和酯是难以接受的底物，而游离羧酸根本不被转化。唯一的例外是 α,β-不饱和二酸、二酯以及在 α-或 β-位带有吸电子基团的酯。在这里，我们提出了一种替代方法，该方法具有直接获得各种手性 α-取代羧酸的普遍适用性。这种方法在同时进行的还原-氧化生物催化级联中结合了两种酶，即 ER 和醛脱氢酶 (Ald-DH)。该策略具有几个优点，因为起始材料是 α-取代的 α,β-不饱和醛，这是一类对烯烃部分的还原具有极强反应性的化合物。例如葡萄糖、甲酸盐）是必需的，因为用于第一还原步骤的氢化物在第二氧化步骤中释放。这样的过程被定义为借氢级联。该方法具有广泛的适用性，因为它成功地应用于手性取代的氢化肉桂酸、脂肪酸、杂环化合物甚至

  DOI：

  10.1039/c4ob02282c
• 作为产物：
  描述：

  2-(2-丙炔氧基)苯甲醛 在 ammonium dihydrogen phosphate 、 copper(l) iodide 作用下， 以 乙腈 为溶剂， 生成 2H-色烯-3-甲醛
  参考文献：
  名称：

  通过CuI /（NH 4）2 HPO 4催化O-炔丙基水杨醛与活性亚甲基化合物的反应有效合成2 H -chromen-3-yl衍生物

  摘要：

  在使用CuI /（NH 4）2 HPO 4催化制备5 H -chromeno [3,4- c ]吡啶的过程中，已经偶然形成了具有不同结构特征的2 H -Chromen-3-基-亚甲基丙二腈/氰基丙烯酸酯/氰基丙烯酰胺。的反应ø -propargyl水杨醛与丙二腈/氰基乙酸乙酯/氰基丙烯酰胺。该方法方便，快速且高产率，并且通过X射线衍射分析最终表征了形成的产物。

  DOI：

  10.1016/j.tet.2012.10.066

文献信息

• [EN] TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS<br/>[FR] TRAITEMENT OU PROPHYLAXIE D'ÉTATS PROLIFÉRATIFS
  申请人：UNIV DUNDEE

  公开号：WO2010125350A1

  公开（公告）日：2010-11-04

  The invention relates to novel compounds for use in the treatment or prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express cytochrome P450 1B1 (CYP1B1) and allelic variants thereof. The invention also provides pharmaceutical compositions comprising one or more such compounds for use in medical therapy, for example in the treatment of prophylaxis of cancers or other proliferative conditions, as well as methods for treating cancers or other conditions in human or non-human animal patients. The invention also provides methods for identifying novel compounds for use in the treatment of prophylaxis of cancers and other proliferative conditions that are for example characterized by cells that express CYP1 B1 and allelic variants thereof. The invention also provides a method for determining the efficacy of a compound of the invention in treating cancer.

  该发明涉及用于治疗或预防癌症和其他增殖性疾病的新化合物，例如这些疾病的特征是细胞表达细胞色素P450 1B1（CYP1B1）及其等位基因变体。该发明还提供包含一种或多种此类化合物的药物组合物，用于医学治疗，例如用于治疗或预防癌症或其他增殖性疾病，以及用于治疗人类或非人类动物患者的癌症或其他疾病的方法。该发明还提供用于识别用于治疗或预防癌症和其他增殖性疾病的新化合物的方法，例如这些疾病的特征是细胞表达CYP1B1及其等位基因变体。该发明还提供一种用于确定该发明中化合物治疗癌症的疗效的方法。
• Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-<i>c</i>]chromene derivatives following hetero-Diels–Alder reaction and<i>in vitro</i>anticancer studies
  作者：Pravati Panda、Sabita Nayak、Susanta Ku. Sahoo、Seetaram Mohapatra、Deepika Nayak、Rajalaxmi Pradhan、Chanakya Nath Kundu

  DOI：10.1039/c8ra02729c

  日期：——

  development of concise methods for the synthesis of small functionalised spirocyclic molecules is important in the search of new bioactive molecules. To contribute this, here we represent a diastereoselective oxa-hetero-Diels–Alder reaction for the synthesis of novel spiro indanone fused pyrano[3,2-c]chromene derivatives and studied their in vitro anticancer activities. Using previously less explored cyclic

  开发用于合成小的功能化螺环分子的简明方法对于寻找新的生物活性分子很重要。为此，我们在这里代表了一种非对映选择性氧杂-杂-Diels-Alder 反应，用于合成新型螺茚满酮稠合吡喃并[3,2- c ]色烯衍生物，并研究了它们的体外抗癌活性。使用以前较少探索的环酮，即茚满-1,3-二酮和3-乙烯基-2 H-色烯衍生物，我们在“类药物”分子和天然产物之间的界面处获得了新型螺杂环骨架。各种螺茚满酮稠合吡喃[3,2- c在 120 °C 回流条件下，使用 4 Å MS 作为添加剂，在甲苯中以高产率（高达 85%）合成了具有四元立体中心的 ]色烯衍生物，具有优异的非对映选择性。这些化合物对 MCF-7（乳腺癌）、HCT-116（结肠癌）、H-357（口腔癌）、MD-MB-231（乳腺癌）细胞系的体外细胞毒性研究通过 MTT 3- (4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑}体外测定。筛选结果显示，与商业抗癌药物
• Efficient Syntheses of New Heteroarotinoids through Functional Pyridylzinc Reagents and Palladium-Catalyzed Cross-Coupling Reactions
  作者：Mouâd Alami、Jean-François Peyrat、Larbi Belachmi、Jean-Daniel Brion

  DOI：10.1002/1099-0690(200111)2001:22<4207::aid-ejoc4207>3.0.co;2-3

  日期：2001.11

  rings in association with pyridyl or ethynylpyridyl moieties, from 6-bromo-2-pyridylzinc chloride (11) is described. This new functional heteroarylzinc reagent, readily accessible from 2,6-dibromopyridine, may undergo a selective palladium-catalyzed carbon−carbon bond-forming reaction to yield the corresponding 6-substituted-2-bromopyridines 13. Further manipulation of the remaining bromine atom in 13

  描述了由 6-溴-2-吡啶基氯化锌 (11) 聚合合成带有色烯环和吡啶基或乙炔基吡啶基部分的杂芳烃类化合物 4、5a 和 5b。这种新的功能杂芳基锌试剂很容易从 2,6-二溴吡啶中获得，可以进行选择性钯催化的碳-碳键形成反应，以产生相应的 6-取代-2-溴吡啶 13。 13得到锌衍生物14，随后在钯催化条件下与4-碘苯甲酸乙酯偶联得到杂芳烃4。取代的溴吡啶13或三氟甲磺酸酯22与适当的炔烃在Sonogashira条件下偶联得到相应的杂芳烃5a、5b和6 .
• Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2 H -chromene and coumarin scaffold
  作者：Violina T. Angelova、Violeta Valcheva、Nikolay G. Vassilev、Rosen Buyukliev、Georgi Momekov、Ivan Dimitrov、Luciano Saso、Mirjana Djukic、Boris Shivachev

  DOI：10.1016/j.bmcl.2016.11.071

  日期：2017.1

  the synthesis of new 2H-chromene or coumarin based acylhydrazones, which were evaluated for their in vitro antimycobacterial activity against reference strain Mycobacterium tuberculosis H37Rv and compared to the first-line antituberculosis drugs, isoniazid (INH) and ethambutol (EMB). The most active compounds 7m (MIC 0.13 μM), 7o (MIC 0.15 μM) and 7k (MIC 0.17 μM) demonstrated antimycobacterial activity

  这项研究报告了新的基于2 H-色烯或香豆素的酰基hydr的合成，评估了它们对参考菌株结核分枝杆菌H37Rv的体外抗分枝杆菌活性，并与一线抗结核药物异烟肼（INH）和乙胺丁醇（EMB）进行了比较。活性最高的化合物7m（MIC 0.13μM），7o（MIC 0.15μM）和7k（MIC 0.17μM）在亚微摩尔浓度水平下表现出抗分枝杆菌活性，并且在人类胚胎肾细胞系HEK-293T中具有显着的相关细胞毒性。已经建立了这类化合物的构效关系。
• Thieme Chemistry Journal Awardees - Where Are They Now? Microwave-Assisted Rhodium-Catalyzed Decarbonylation of Functionalized 3-Formyl-2<i>H</i>-chromenes: A Sequence for Functionalized Chromenes like Deoxycordiachromene
  作者：Stefan Bräse、Manuel Bröhmer、Nicole Volz

  DOI：10.1055/s-0029-1217179

  日期：——

  3-Formyl-2H-chromenes which are readily accessible through an oxa-Michael reaction of salicylaldehydes and α,β-unsaturated aldehydes undergo a smooth decarbonylation reaction upon treatment with rhodium catalysts. With our method, a great variety of functionalized chromenes is accessible in a two-step sequence from salicylaldehydes.

  3-甲酰基-2H-色烯可通过水合物迈克尔反应，由水杨醛和α，β-不饱和醛轻易制得。这些化合物在铑催化剂作用下会顺利进行脱羰反应。运用我们的方法，可通过水杨醛的两步反应，大量制备功能化色烯。

表征谱图